ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹30 Cr | ₹28 Cr | ₹25 Cr | ₹20 Cr | ₹17 Cr |
What is the latest Contingent Liabilities ratio of ERIS LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹30 Cr |
Mar2023 | ₹28 Cr |
Mar2022 | ₹25 Cr |
Mar2021 | ₹20 Cr |
Mar2020 | ₹17 Cr |
How is Contingent Liabilities of ERIS LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹30 Cr | 7.30 | |
Mar2023 | ₹28 Cr | 15.82 | |
Mar2022 | ₹25 Cr | 25.02 | |
Mar2021 | ₹20 Cr | 14.68 | |
Mar2020 | ₹17 Cr | - |
Compare Contingent Liabilities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹18,729.4 Cr | 1.7% | 7.8% | 46.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | 1.7% |
7.8% |
46.5% |
SENSEX | 1.8% |
-2.5% |
19.9% |
You may also like the below Video Courses